Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...

The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).

The Food and Drug Administration Safety and Innovation Act (FDASIA), signed into law on July 9, 2012, introduced several reforms that are intended to streamline the FDA's premarketing approval process ...

In the commercial and business field it is common to use almost indistinctively expressions such as corporate name and trade name or designation. However, these expressions must be clearly specified ...

Fortude continues to help global enterprises maximize value on Azure by delivering expert cloud guidance, modernization ...